Midatech Pharma PLC (MTP)

NASDAQ: MTP · IEX Real-Time Price · USD
0.626
0.016 (2.64%)
May 27, 2022 3:52 PM EDT - Market closed
Market Cap12.36M
Revenue (ttm)770,667
Net Income (ttm)-7.28M
Shares Out19.74M
EPS (ttm)-0.43
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume22,095
Open0.649
Previous Close0.610
Day's Range0.570 - 0.649
52-Week Range0.380 - 3.610
Beta1.54
AnalystsSell
Price Targetn/a
Earnings DateApr 29, 2022

About MTP

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-actin...

IndustryBiotechnology
Founded2000
Employees20
Stock ExchangeNASDAQ
Ticker SymbolMTP
Full Company Profile

Financial Performance

In 2021, MTP's revenue was 578,000, an increase of 68.51% compared to the previous year's 343,000. Losses were -5.46 million, -75.39% less than in 2020.

Financial numbers in millions GBPFinancial Statements

News

Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM

ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines...

3 days ago - Accesswire

Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, anno...

1 month ago - Accesswire

Midatech Pharma PLC Announces Receipt of NASDAQ Notice

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine...

1 month ago - Accesswire

Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule

ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is plea...

2 months ago - Accesswire

Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser

ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is pleas...

2 months ago - Accesswire

Midatech Pharma PLC Announces Extension of Janssen collaboration re Q-Sphera

Midatech announces extension of R&D collaboration with Janssen focused on Q-Sphera technology ABINGDON, UK / ACCESSWIRE / January 17, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery t...

4 months ago - Accesswire

Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective

Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:...

5 months ago - Accesswire

Midatech Pharma PLC Announces Notice of Interim Results

ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medic...

8 months ago - Accesswire

Midatech Pharma PLC Announces Appointment of Chief Scientific Officer

Midatech Pharma PLC ('Midatech' or the 'Company') Midatech Strengthens Management Team with Appointment of Dr. Dmitry Zamoryakhin as Chief Scientific Officer ABINGDON, OXFORDSHIRE / ACCESSWIRE / July 12...

10 months ago - Accesswire

Midatech Pharma Secures £10M In Equity To Fund Product Development

Midatech Pharma plc (NASDAQ: MTP) has raised £10 million from equity placing to fund its product development pipeline. Approximately 35 million new shares in the Company were issued at 28.5p each, a 12%...

10 months ago - Benzinga

MTP Stock: The Big Midatech Pharma News That Has Shares Rocketing Today

Shares of MTP stock are skyrocketing on Thursday following news of positive results from a portion of Midatech Pharma's technology. The post MTP Stock: The Big Midatech Pharma News That Has Shares Rocke...

11 months ago - InvestorPlace

Midatech Pharma Stock Jumps After Breakthrough Data On Encapsulation Of Biologic Using Q-Sphera

Midatech Pharma PLC (NASDAQ: MTP) has announced a breakthrough in vitro data utilizing Q-Sphera technology and progress across multiple other programs. The technology showed potential to formulate prote...

11 months ago - Benzinga

Midatech Pharma PLC Announces Breakthrough Data Using Q-Sphera Technology

Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technology Significant progress across multiple other R&D programmes ABINGDON, OXFORDSHIRE/ ACCESSWIRE / June 17, 2021 / Mi...

11 months ago - Accesswire

Midatech Pharma PLC Announces Investor Webinar Scheduled for 17 June 2021

ABINGDON, UK / ACCESSWIRE / June 9, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, will b...

11 months ago - Accesswire

Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020

Preliminary Results for the Year Ended 31 December 2020 ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 30, 2021 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), a drug delivery technology company focused o...

1 year ago - Accesswire

Midatech Pharma PLC Announces MTX110 Update & Headline Results for 2020

Non-binding Heads of Terms for Co-development of MTX110; Unaudited Headline Results for the Year Ended 31 December 2020 ABINGDON, UK / ACCESSWIRE / March 25, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASD...

1 year ago - Accesswire

Midatech Pharma News: Why MTP Stock Is Surging 10% Today

Midatech Pharma (MTP) news for Monday includes positive results from a Phase I study of a DIPG treatment boosting MTP stock higher. The post Midatech Pharma News: Why MTP Stock Is Surging 10% Today appe...

1 year ago - InvestorPlace

Midatech Pharma News: Why MTP Stock Is Soaring 56% Today

Midatech Pharma (MTP) news for Friday includes talk from the company about reselling roughly 12.7 million shares pushing MTP stock higher. The post Midatech Pharma News: Why MTP Stock Is Soaring 56% Tod...

1 year ago - InvestorPlace

Midatech Pharma News: Why MTP Stock Is Skyrocketing 154% Today

Midatech Pharma (MTP) news for Tuesday concerning a collaboration deal involving the Q-Sphera platform has MTP stock taking off. The post Midatech Pharma News: Why MTP Stock Is Skyrocketing 154% Today a...

1 year ago - InvestorPlace

Midatech Pharma News: MTP Stock Rockets on Diabetes Vaccine Results

A stronger diabetes vaccine may be what the doctor will order soon as Midatech Pharma's clinical trial were "positive." MTP stock is up.

2 years ago - InvestorPlace

Midatech Pharma Rallies On Positive MTX102 Results

Midatech Pharma PLC-ADR (NASDAQ: MTP) shares were trading higher Friday after the company announced positive results from a first-in-human study of its MTX102 immuno-tolerizing vaccine product candidate...

2 years ago - Benzinga

Midatech's stock rockets on heavy volume after positive results from diabetes treatment study

The U.S.-listed shares of Midatech Pharma PLC rocketed 113% on very heavy volume in premarket trading Friday.

2 years ago - Market Watch